144 related articles for article (PubMed ID: 33618082)
21. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
[TBL] [Abstract][Full Text] [Related]
22. Development and Comparison of Nanosponge and Niosome based Gel for the Topical Delivery of Tazarotene.
Aggarwal G; Nagpal M; Kaur G
Pharm Nanotechnol; 2016; 4(3):213-228. PubMed ID: 29052500
[TBL] [Abstract][Full Text] [Related]
23. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
24. Arbutin encapsulated micelles improved transdermal delivery and suppression of cellular melanin production.
Liang K; Xu K; Bessarab D; Obaje J; Xu C
BMC Res Notes; 2016 Apr; 9():254. PubMed ID: 27129306
[TBL] [Abstract][Full Text] [Related]
25. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
[TBL] [Abstract][Full Text] [Related]
26. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
[TBL] [Abstract][Full Text] [Related]
27. Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains.
Rahmati M; Babapoor E; Dezfulian M
World J Microbiol Biotechnol; 2022 Oct; 38(12):230. PubMed ID: 36184645
[TBL] [Abstract][Full Text] [Related]
28. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
Jukanti R; Sheela S; Bandari S; Veerareddy PR
J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
[TBL] [Abstract][Full Text] [Related]
29. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Dasgupta S; Ghosh SK; Ray S; Mazumder B
Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
[TBL] [Abstract][Full Text] [Related]
30. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment.
Mali N; Darandale S; Vavia P
Drug Deliv Transl Res; 2013 Dec; 3(6):587-92. PubMed ID: 25786376
[TBL] [Abstract][Full Text] [Related]
31. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
32. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive review of the therapeutic potential of α-arbutin.
Saeedi M; Khezri K; Seyed Zakaryaei A; Mohammadamini H
Phytother Res; 2021 Aug; 35(8):4136-4154. PubMed ID: 33724594
[TBL] [Abstract][Full Text] [Related]
34. Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac).
Akbari J; Saeedi M; Morteza-Semnani K; Hashemi SMH; Babaei A; Eghbali M; Mohammadi M; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
J Drug Target; 2022 Jan; 30(1):108-117. PubMed ID: 34116599
[TBL] [Abstract][Full Text] [Related]
35. A novel niosome formulation for encapsulation of anthocyanins and modelling intestinal transport.
Fidan-Yardimci M; Akay S; Sharifi F; Sevimli-Gur C; Ongen G; Yesil-Celiktas O
Food Chem; 2019 Sep; 293():57-65. PubMed ID: 31151649
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
[TBL] [Abstract][Full Text] [Related]
37. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
[TBL] [Abstract][Full Text] [Related]
38. Topical Amphotericin B solid lipid nanoparticles: Design and development.
Butani D; Yewale C; Misra A
Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
[TBL] [Abstract][Full Text] [Related]
39. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
40. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
